Vaccine Development Professionals to Know 2025

Emanuele Andreano is an immunologist and biotech innovator redefining how vaccines are discovered for pandemic threats. As Head of Serology and Immunology at the Fondazione Biotecnopolo di Siena and a leader in the European Vaccine Hub, he works at the intersection of AI, immunology, and global health. He pioneered Reverse Vaccinology 3.0, a breakthrough approach that can identify entirely new vaccine targets in days instead of years. In a first-of-its-kind demonstration, his team showed that artificial intelligence can predict unknown viral antigens directly from human antibody sequences—effectively reversing the traditional vaccine discovery process. His work spans monoclonal antibody discovery and next-generation vaccines against emerging pathogens, including mpox and SARS-CoV-2, with direct implications for global pandemic preparedness and biosecurity. Andreano has received international recognition, including the Antonio Feltrinelli Prize from the Accademia Nazionale dei Lincei, awarded in the presence of the President of the Italian Republic Sergio Mattarella, the IUIS Rising Star in Immunology, and a European Research Council (ERC) grant. He also co-directs a vaccinology program at the Institut Pasteur in Paris. “We are entering an era where vaccines can be discovered at unprecedented speed—transforming our ability to fight pandemics and save countless lives.”

Dr. James Utley is a pioneering scientist at the forefront of cellular therapy, AI, and data science. A Johns Hopkins-educated Immunohematology expert and Certified Advanced Biotherapies Professional (CABP), he also holds advanced certifications in data science and machine learning. While serving as Technical Director at a major healthcare organization, Dr. Utley oversaw more than 150,000 successful cellular transfusions and spearheaded advancements that significantly improved patient outcomes. This experience included leading initiatives for the Department of Defense, where he revolutionized cellular transfusion practices. His innovative approach is further exemplified by his FDA-approved work and numerous publications in leading scientific journals. Dr. Utley is also known for his bold, hands-on approach to research, embodying the spirit of a "biohacker" by pushing the boundaries of CRISPR and genetic engineering through self-experimentation. This unique blend of rigorous scientific training and unconventional methods has earned him the moniker "the pirate" within the biohacker community.

Macay Hunter is a manufacturing executive specializing in custom plastic component production, with expertise spanning injection molding, structural foam molding, and advanced polymer processing technologies. He currently serves in a senior commercial leadership role, where he focuses on helping OEMs and product manufacturers bring complex plastic parts from concept through production. Macay’s work sits at the intersection of engineering, operations, and supply chain strategy. He partners closely with mechanical engineers, sourcing leaders, and program managers to evaluate manufacturability, tooling strategy, material selection, and long-term production scalability. His experience supports programs across highly regulated and performance-critical sectors, including medical device, aerospace and defense, industrial equipment, and commercial products. Known for a consultative and design-for-manufacturability driven approach, Macay is particularly focused on aligning part design, process selection, and tooling investment with program risk, lifecycle demand, and cost optimization. He frequently collaborates with customers early in development to identify geometry improvements, cycle time efficiencies, and structural performance enhancements before production launch. In addition to commercial leadership, Macay is actively engaged in building modern sales and marketing infrastructure within the manufacturing sector. He leverages digital prospecting tools, intent data, and CRM automation to develop scalable top-of-funnel engagement strategies that connect engineering organizations with the right manufacturing partners. Macay is an advocate for U.S. manufacturing and supplier partnership models that balance quality control, capacity resilience, and supply chain continuity. Through industry engagement and thought leadership, he contributes perspectives on sourcing strategy, tooling investment, and production risk management in complex plastic part programs.

Clinical trial management of two stem cell clinical trials. I have a passion for data science analytics and rigorous pattern-seeking. I believe in leading from the front and making sure the team is well taken care of. *Managing 2 stem cell clinical trials, NCT02838316 and NCT05421689*30 peer-reviewed publications.*>12,000 citations.*2 provisional patents.*Co-founded startup.*Co-developed departmental leadership program.*Strong track record of grant funding and collaboration building.* Associated Editor for two flagship scientific journals (Stem Cells, Journal of Extracellular Biology).GOOGLE SCHOLAR PROFILEhttps://scholar.google.com/citations?user=3uQtjEEAAAAJ&hl=en

I entered the hemp space at the very beginning when there were almost no guardrails, no industry playbook, and very few operators who truly understood what it took to formulate something that actually worked. Hemp-derived flower and hemp wellness products were barely a category. What existed was largely untested, poorly sourced, and built around novelty rather than need. From day one, our approach was different purpose before profit, formulation before marketing, and a deep belief that every formulation should serve a real purpose. At JustKana, I oversee product development, quality control, and sourcing from the ground up. That means building relationships directly with small-batch organic hemp farms, evaluating raw material quality before it ever reaches a formulation stage, and ensuring every finished product meets both our internal standards and third-party lab verification. My work lives at the intersection of plant science and consumer wellness. I specialize in cannabinoid formulation for real therapeutic outcomes sleep support, chronic pain relief, anxiety management, and inflammation using full-spectrum hemp extracts that preserve the natural compound profile of the plant rather than isolating single ingredients. Over the years I've helped develop products that have made a measurable difference for thousands of people veterans managing PTSD, seniors dealing with chronic joint pain, and individuals looking to replace pharmaceutical sleep aids with something cleaner and plant-derived. That direct connection to consumer outcomes shapes every formulation decision I make. I understand the hemp supply chain from soil to finished product cultivation practices, extraction methods, cannabinoid and terpene profiles, and how sourcing decisions downstream directly impact what a customer experiences. In a space flooded with white-labeled, mass-produced products, that depth of knowledge is rare.

Dr. Frank D. Yelian, MD, PhD, is the Founder and Director of Life IVF Center, one of the West Coast's largest independent fertility practices. At Life IVF, he leads a highly specialized fertility program focused on delivering results in the most challenging cases. With dual training as a physician and scientist, Dr. Yelian combines rigorous clinical expertise with a deep understanding of reproductive biology to develop highly individualized treatment strategies. Dr. Yelian is widely recognized for his work with patients who have experienced prior IVF failure, particularly those with diminished ovarian reserve (DOR), advanced maternal age, and other complex diagnoses. His clinical approach centers on Precision IVF® protocols, which emphasize careful calibration of medication dosing to align with each patient’s unique physiology. This method is designed to maximize treatment effectiveness while reducing unnecessary medication costs and limiting exposure to potentially harmful side effects. At Life IVF Center, Dr. Yelian has built a reputation for treating patients that many clinics decline. His program consistently achieves successful outcomes in cases considered low probability, supported by advanced diagnostics, refined stimulation strategies, and a high-performance embryology laboratory. In addition to his work with complex IVF cases, Dr. Yelian has extensive experience in travel IVF, egg donation, and gestational surrogacy, providing comprehensive solutions for both domestic and international patients. His ability to manage intricate clinical scenarios across these pathways has made Life IVF Center a destination for patients seeking expertise beyond standard fertility care. Dr. Yelian’s work is defined by a commitment to precision, innovation, and results, establishing Life IVF Center as a leader in advanced reproductive medicine for patients who require a more sophisticated and individualized approach.

Adrian Wadowski is the Brand Director at CamelWay, Europe's premier producer of functional camel milk. He is a leading voice on the therapeutic applications of alternative dairy, specifically for metabolic health (Type 1 & 2 Diabetes) and autoimmune support. Adrian specializes in the "Gut-Skin Axis", educating on how Lactoferrin and IgG can support recovery from Eczema and Psoriasis. He is also an advocate for Casomorphin-free (GFCF) diets to support neurodiversity and Autism therapy. He oversees EU-certified production using advanced low-temperature spray drying technology, ensuring the preservation of bioactive proteins often lost in standard processing.

Dr. Akshaya Srikanth Bhagavathula is an Associate Professor of Epidemiology at North Dakota State University, internationally recognized for his pioneering work at the intersection of digital epidemiology, pharmacovigilance, and artificial intelligence. His research harnesses advanced statistical modeling and AI to track and predict health behaviors, medication safety, and disease patterns in real time—bridging traditional epidemiology with next-generation digital health analytics. Dr. Bhagavathula has published more than 250 peer-reviewed articles in leading journals, including Annals of Epidemiology, JAMA Network Open, and Lancet Digital Health. His work has been widely cited and featured in major media outlets such as The New York Times, where he discussed the real-world safety of GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy, Mounjaro). Recognized among the Stanford–Elsevier Top 2% of Scientists (2019–2024) and elected as a Fellow of the American College of Epidemiology, Dr. Bhagavathula is known for translating complex data into actionable insights that shape public health policy and clinical practice. His ongoing projects include NIH- and NSF-aligned initiatives on AI-powered overdose forecasting, digital twins for public health, and real-world drug safety surveillance using explainable machine learning. With a decade of experience spanning more than two dozen countries and collaborations with organizations such as WHO, USAID, and UNICEF, Dr. Bhagavathula brings a global, data-driven, and human-centered approach to solving modern health crises.

I am an MD-PhD physician-scientist with a passion for translating complex clinical and scientific data into clear, accurate content. My training and experience span clinical practice and translational research, with expertise across oncology, immunology, gastroenterology, inflammation & metabolism, and rare diseases. With over 10 years of experience, I have supported key deliverables including more than 30 peer-reviewed publications, manuscripts, slide decks, literature reviews, and scientific narratives. I enjoy working in collaborative, deadline-driven environments and am particularly interested in medical writing, medical information, and publication development, where scientific accuracy and effective storytelling intersect.

Shane Hellmrich holds a BSc in Health Promotion and has spent the past 11 years independently testing and reviewing online modafinil vendors — placing personal test orders, verifying product authenticity, and documenting shipping reliability across dozens of suppliers. His work at BuyModa.net tracks over 1,300 verified customer transactions and maintains a public testing methodology that has become a trusted reference point for consumers navigating the grey-market pharmaceutical space. Shane's research covers vendor reliability scoring, product authentication, shipping logistics across international jurisdictions, and the pharmacokinetic profiles of generic modafinil products. He is regularly consulted on topics including nootropics and cognitive enhancement, online pharmacy safety and regulation, pharmaceutical sourcing and supply chain transparency, consumer protection in unregulated markets, and the real-world usage patterns of prescription cognitive enhancers. Shane is available for expert commentary, background briefings, and on-the-record quotes for journalists covering health, productivity, pharmacology, biohacking, and consumer safety.

Clinically trained veterinarian with experience in gastroenterology, internal medicine, and emergency care. Veterinary physician-scientist specializing in clinical research, diagnostic development, and translational medicine in companion animals, supporting research initiatives in oncology and internal medicine. Skilled in clinical sample characterization and biobank operations, including medical record review of 4,000+ veterinary cases and collaboration with academic and clinical partners. Holds a PhD in Biomedical Sciences focused on cell biology and organoid technology with multiple pending patents, with experience in disease modeling and scientific publication. Regularly collaborates with senior leadership to align cross-functional teams and advance complex research initiatives, complemented by an MBA focused on strategy and project management.

Dr. Boluwatife OLU Afolabi is a dental surgeon and PhD candidate in Oral Biology at the University of Minnesota School of Dentistry. His research focuses on the molecular mechanisms driving head and neck squamous cell carcinoma, particularly the role of environmental carcinogens, inflammatory signaling, and transcriptional regulation in disease initiation and progression. His work investigates pathways such as the Aryl Hydrocarbon Receptor (AHR) and S100A8/S100A9-mediated inflammatory responses using cellular and molecular models of oral epithelial transformation. He has extensive experience in cancer biology, oral pathology, toxicology, and translational biomedical research. Dr. Afolabi provides expert insight on oral cancer risk factors, environmental exposures and health, inflammation and disease mechanisms, dental-systemic health connections, and emerging directions in cancer research. He is also interested in public health implications of carcinogen exposure and prevention strategies in oral and head-and-neck disease.

I’m an accomplished talent development and learning professional, experienced in all aspects of learning and development and leadership development. Including assessment, design, development, delivery and evaluation. In addition I’m a dynamic trainer / facilitator with over 20 years of professional experience.M. Ed. in Training and Adult Learning, DDI Master Certified.Specialties:-Training Assessment / Analysis (working with SME's)-Instructional Design / Development -elearning and podcasting-Training Delivery (Instruction and Facilitation)-Virtual training delivery (WebEx, LearningLive, Zoom)-Sales / Business Development / Customer Service-Leadership-Motivation-Emotional Intelligence-Presentation Skills-Conflict Management-Difficult Conversations-Coaching-Time Management-Onboarding

I am the Co-Founder and Chief Product Officer at Mantalys, an AI start-up based in Toulouse, France dedicated to bringing lightweight, high-performance AI solutions to biomedical image analysis. With a PhD in neuro-immunology and five years of post-doctoral research experience in tumor immunology, I bring deep biomedical expertise to the computer vision team - bridging science and technology to unlock real world insights and extract actionable intelligence from biomedical images.

Ryan Farmer is the founder of My Peptide Match, a consumer education site that helps people make sense of GLP-1 medications and the fast-changing peptide landscape. He focuses on simplifying complex topics—like real-world pricing, treatment pathways, sourcing differences, and what questions to ask—so readers can make more informed decisions with their clinician. Ryan tracks emerging trends across weight-loss peptides, compounding and telehealth access, and the economics that shape what consumers actually pay. He’s available to comment on GLP-1 and peptide cost comparisons, patient decision-making, and the broader market shifts driving demand. He also publishes practical reference tools, including a peptide calculator and dosage guide, to support clearer conversations between consumers and providers.

Deepak Kumar, MSc Nursing I am a dedicated MSc Nursing Officer with over 3 years of intensive clinical experience in the ICU (Intensive Care Unit). My professional mission is to bridge the gap between academic nursing textbooks and real-world bedside clinical practice. As the founder of Bexyhub, I specialize in translating complex medical research into actionable, high-utility clinical pearls for healthcare professionals and students. My expertise includes Critical Care Management, Patient Safety Protocols, Advanced Nursing Procedures, and Medical Research Analysis. I am committed to providing unique, evidence-based insights that are not found in standard textbooks, grounded in my daily experience handling critical life-saving situations

He is Manish Gupta, a graduate from AKTU University in Lucknow. He began his journey as a project assistant at IIT Kanpur before embracing the world of words and wellness. A qualified pharmacist, he founded Medicovada health and wellness platform where he now writes and shares trusted insights. His work also powers VadaCare Insights, which reaches over 10k monthly visitors. Through his writing, he brings clarity to health, one article at a time.

I am a founder of Veedma ➡️ Veedma.com It's a telehealth clinic that helps men optimize their hormones and reach peak performance. Most men with hormone issues are told their labs are normal or are given generic treatment without understanding the cause. I founded Veedma to change that. We use comprehensive lab panels and medical history data to identify where the system breaks down and provide real medical care. Past ventures: - Led a Urology department at an IVF clinic - Moved to Silicon Valley and built health tech products Impressive milestones: - Helped over 400 couples overcome infertility and become parents Current journey: Helping founders in their 40s reclaim the energy to outperform Stanford-dropout competitors.

Vinothkumar Kolluru is a Senior Data Scientist at Fractal Analytics with 9+ years of experience in NLP, Machine Learning, and Deep Learning. He builds AI-driven solutions that improve customer experience and decision-making, with a focus on customer segmentation, friction detection, and digital journey optimization for large-scale web platforms. He has delivered end-to-end models across tech, healthcare, and marketing—ranging from NLP-based document summarization and topic categorization to predictive analytics—using transformer architectures (e.g., BERT), sequence models, and classical ML. Vinoth has also led analytics initiatives such as call categorization for healthcare contact centers and relevance modeling to improve campaign targeting and performance. A passionate researcher and contributor to the AI community, Vinoth has 50+ publications and 246 citations (h-index 9). He is recognized with the Dr. Abdul Kalam Young Achiever National Award and holds an MS in Data Science from Stevens Institute of Technology, along with a Gold Medal in Engineering from Anna University. His core toolkit includes Python, SQL, AWS, and Azure, and he enjoys translating complex data into practical, measurable business impact.

Dhyey is an AI & computational math researcher at Amherst College. His work sits between statistical learning and mathematical rigor, developing methods and software for robust modeling, efficient computation, and machine-assisted reasoning. He's especially interested in bridging foundations (proofs, geometry, probability) with practical ML systems. Previously he has published novel open-source Python packages amassing 40k+ downloads, and published papers with professors and executives of Fortune 500 companies. He's an active guest author and contributing writer to major industry media publications such as VentureBeat, LeadDev, DZone, etc.